CBIO position history
The shares of Crescent Biopharma (CBIO) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 2,356,600 shares, $28M, 3.7% of portfolio, New
- 2026 Q1: 1,312,615 shares, $24M, 3.2% of portfolio, Reduce −44.3%
- 2026 Q2: 1,319,351 shares, $24M, 2.2% of portfolio, Add +0.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|